The difference of the inflammatory milieu in MIS-C and severe COVID-19.

Sibel Lacinel GurlevikYasemin OzsurekciErdal SağP Derin OygarSelman KesiciÜmmüşen Kaya AkcaMuserref Kasap CuceogluOzge BasaranSultan GöncüJale KarakayaAli Bülent CengizSeza Özen

Published in: Pediatric research (2022)

This study defines a pattern of distinctive immune responses in children with MIS-C and in patients with severe/critical COVID-19. As the COVID-19 pandemic continues, biomarkers to identify MIS-C risk are needed to guide our management that study results may shed light on it.

Keyphrases

coronavirus disease
sars cov
immune response
early onset
young adults
toll like receptor
dendritic cells
drug induced